MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Weigang 1, Nanjing, Jiangsu, 210095, China.
Department of Pathology, The University of Chicago, Chicago, IL, USA.
Cell Death Differ. 2018 Sep;25(9):1657-1670. doi: 10.1038/s41418-018-0070-2. Epub 2018 Feb 19.
The regeneration of intestinal epithelial are maintained by continuous differentiation and proliferation of intestinal stem cells (ISCs) under physiological and pathological conditions. However, little is known about the regulatory effect of intestinal microbiota on its recovery ability to repair damaged mucosal barrier. In this study, we established intestinal organoids and lamina propria lymphocytes (LPLs) co-cultured system, plus mice experiments, to explore the protective effect of Lactobacillus reuteri D8 on integrity of intestinal mucosa. We found that only live L. reuteri D8 was effective in protecting the morphology of intestinal organoids and normal proliferation of epithelial stained with EdU under TNF-α treatment, which was also further verified in mice experiments. L. reuteri D8 colonized in the intestinal mucosa and ameliorated intestinal mucosa damage caused by DSS treatment, including improvement of body weight, colon length, pathological change, and proliferation level. The repair process stimulated by L. reuteri D8 was also accompanied with increased numbers of Lgr5 and lysozyme cells both in intestinal organoids and mice intestine. Furthermore, we demonstrated that D8 metabolite indole-3-aldehyde stimulated LPLs to secret IL-22 through aryl hydrocarbon receptor (AhR) and then induced phosphorylation of STAT3 to accelerate proliferation of intestinal epithelial, thus recovering damaged intestinal mucosa. Our findings indicate L. reuteri protects intestinal barrier and activates intestinal epithelial proliferation, which sheds light on treatment approaches for intestinal inflammation based on ISCs with probiotics Lactobacillus and daily probiotic consumption in heath foods.
在生理和病理条件下,肠道干细胞(ISCs)的持续分化和增殖维持着肠道上皮的再生。然而,肠道微生物群对其修复受损黏膜屏障的恢复能力的调节作用知之甚少。在这项研究中,我们建立了肠道类器官和固有层淋巴细胞(LPLs)共培养系统,结合小鼠实验,探索了罗伊氏乳杆菌 D8 对肠道黏膜完整性的保护作用。我们发现,只有活的罗伊氏乳杆菌 D8 在 TNF-α处理下,对肠道类器官的形态和上皮细胞的 EdU 染色正常增殖有保护作用,这在小鼠实验中也得到了进一步验证。D8 定植在肠道黏膜中,改善了 DSS 处理引起的肠道黏膜损伤,包括体重、结肠长度、病理变化和增殖水平的改善。D8 刺激的修复过程伴随着肠道类器官和小鼠肠道中 Lgr5 和溶菌酶细胞数量的增加。此外,我们证明了 D8 代谢物吲哚-3-乙醛通过芳香烃受体(AhR)刺激 LPLs 分泌 IL-22,然后诱导 STAT3 磷酸化,加速肠道上皮细胞的增殖,从而恢复受损的肠道黏膜。我们的发现表明罗伊氏乳杆菌保护肠道屏障并激活肠道上皮细胞增殖,这为基于 ISCs 的益生菌和日常益生菌在健康食品中的消费治疗肠道炎症提供了新的思路。